Denali Therapeutics Stock Price on September 5, 2024

DNLI Stock  USD 24.22  0.20  0.82%   
Below is the normalized historical share price chart for Denali Therapeutics extending back to December 08, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Denali Therapeutics stands at 24.22, as last reported on the 22nd of November, with the highest price reaching 24.79 and the lowest price hitting 23.80 during the day.
IPO Date
8th of December 2017
200 Day MA
22.5044
50 Day MA
28.127
Beta
1.394
 
Covid
If you're considering investing in Denali Stock, it is important to understand the factors that can impact its price. Denali Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0084, which denotes the company had a -0.0084% return per unit of risk over the last 3 months. Denali Therapeutics exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Denali Therapeutics' Coefficient Of Variation of 3205.71, downside deviation of 3.77, and Mean Deviation of 2.46 to check the risk estimate we provide.
  
As of now, Denali Therapeutics' Stock Based Compensation is increasing as compared to previous years. The Denali Therapeutics' current Stock Based Compensation To Revenue is estimated to increase to 0.63, while Total Stockholder Equity is projected to decrease to under 712.9 M. . The Denali Therapeutics' current Price Earnings To Growth Ratio is estimated to increase to 0.36, while Price To Sales Ratio is projected to decrease to 8.47. Denali Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0084

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsDNLI

Estimated Market Risk

 3.46
  actual daily
30
70% of assets are more volatile

Expected Return

 -0.03
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average Denali Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Denali Therapeutics by adding Denali Therapeutics to a well-diversified portfolio.
Price Book
2.6569
Enterprise Value Ebitda
(8.66)
Price Sales
3.3 K
Shares Float
130.1 M
Wall Street Target Price
41.6923

Related Headline

Zura Bio Headline on 5th of September 2024

Zura Bio Receives New Coverage from Analysts at HC Wainwright MarketBeat

Denali Therapeutics Valuation on September 5, 2024

It is possible to determine the worth of Denali Therapeutics on a given historical date. On September 5, 2024 Denali was worth 25.25 at the beginning of the trading date compared to the closed value of 25.25. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Denali Therapeutics stock. Still, in general, we apply an absolute valuation method to find Denali Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Denali Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Denali Therapeutics' related companies.
 Open High Low Close Volume
  25.17    25.69    24.62    25.16    702,013  
09/05/2024
  25.25    25.40    24.78    25.25    708,799  
  25.29    25.50    24.47    25.25    695,238  
Backtest Denali Therapeutics  |  Denali Therapeutics History  |  Denali Therapeutics Valuation   PreviousNext  
Open Value
25.25
25.25
Closing Value
35.62
Upside

Denali Therapeutics Trading Date Momentum on September 5, 2024

On September 06 2024 Denali Therapeutics was traded for  25.25  at the closing time. The top price for the day was 25.50  and the lowest listed price was  24.47 . The trading volume for the day was 695.2 K. The trading history from September 6, 2024 did not affect price variability. The overall trading delta against the current closing price is 21.86% .

Denali Therapeutics Fundamentals Correlations and Trends

By evaluating Denali Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Denali Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Denali financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Denali Therapeutics Stock history

Denali Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Denali is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Denali Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Denali Therapeutics stock prices may prove useful in developing a viable investing in Denali Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding137.4 M86.7 M
Net Loss-293.4 M-278.7 M

Denali Therapeutics Quarterly Net Working Capital

853.85 Million

Denali Therapeutics Stock Technical Analysis

Denali Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Denali Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Denali Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Denali Therapeutics Period Price Range

Low
November 22, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Denali Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Denali Therapeutics November 22, 2024 Market Strength

Market strength indicators help investors to evaluate how Denali Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Denali Therapeutics shares will generate the highest return on investment. By undertsting and applying Denali Therapeutics stock market strength indicators, traders can identify Denali Therapeutics entry and exit signals to maximize returns

Denali Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Denali Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Denali Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Denali to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Denali Stock analysis

When running Denali Therapeutics' price analysis, check to measure Denali Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Denali Therapeutics is operating at the current time. Most of Denali Therapeutics' value examination focuses on studying past and present price action to predict the probability of Denali Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Denali Therapeutics' price. Additionally, you may evaluate how the addition of Denali Therapeutics to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments